ono 3307 has been researched along with allopurinol in 2 studies
| Studies (ono 3307) | Trials (ono 3307) | Recent Studies (post-2010) (ono 3307) | Studies (allopurinol) | Trials (allopurinol) | Recent Studies (post-2010) (allopurinol) |
|---|---|---|---|---|---|
| 12 | 0 | 1 | 15,096 | 743 | 3,363 |
| Protein | Taxonomy | ono 3307 (IC50) | allopurinol (IC50) |
|---|---|---|---|
| Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | Rattus norvegicus (Norway rat) | 3.3765 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 3.1861 | |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 5.0758 | |
| Histamine H3 receptor | Cavia porcellus (domestic guinea pig) | 8.69 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, T; Manabe, T; Nio, Y; Ohshio, G | 1 |
| Calne, R; Hirano, T; Manabe, T; Printz, H; Steer, M; Tobe, T | 1 |
2 other study(ies) available for ono 3307 and allopurinol
| Article | Year |
|---|---|
Protective effects of combined therapy with a protease inhibitor, ONO 3307, and a xanthine oxidase inhibitor, allopurinol on temporary ischaemic model of pancreatitis in rats.
Topics: Acute Disease; Allopurinol; Animals; Bile Ducts; Constriction; Drug Therapy, Combination; Guanidines; Ischemia; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Rats; Rats, Wistar; Reperfusion; Serine Proteinase Inhibitors; Xanthine Oxidase | 1992 |
Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats.
Topics: Acute Disease; Allopurinol; Animals; Ceruletide; Cholestasis, Extrahepatic; Drug Therapy, Combination; Guanidines; Ischemia; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Rats; Rats, Wistar; Secretin; Serine Proteinase Inhibitors | 1993 |